Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403078 · ClinicalTrials.gov registry record
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
A clinical trial, sponsored by Cordis US.
- Completed
- Registry status
- 21,008
- Enrollment target
NCT00403078 is a clinical trial that has completed, run by Cordis US. The registered enrollment target is 21,008 participants.
The verdict
NCT00403078 has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- 21,008 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,008 participants |
| Start Date | 2006-10 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00403078
The ClinicalTrials.gov registry entry for NCT00403078 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21,008 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00403078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00403078 about?
NCT00403078 is a clinical study titled "SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy". The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW...
What is the current status of trial NCT00403078?
This trial is currently completed. The enrollment target is 21,008 participants. The study started on 2006-10. Estimated completion is 2014-11.
Who is sponsoring clinical trial NCT00403078?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.